ARTICLE
|
doi:10.20944/preprints202410.0895.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
cancer; NSCLC; EGFR mutations; TKIs; CRISPR
Online: 11 October 2024 (13:30:15 CEST)